Article Text

Download PDFPDF
Pathological lesions in colonic biopsies during Parkinson’s disease
  1. T Lebouvier1,2,3,4,
  2. T Chaumette1,2,3,
  3. P Damier2,4,5,
  4. E Coron1,2,3,5,
  5. Y Touchefeu1,2,3,
  6. S Vrignaud6,
  7. P Naveilhan2,7,
  8. J-P Galmiche1,2,3,5,
  9. S Bruley des Varannes1,2,3,5,
  10. P Derkinderen1,2,3,4,5,
  11. M Neunlist1,2,3,4
  1. 1
    Inserm, U913, Nantes, France
  2. 2
    University Nantes, Nantes, France
  3. 3
    CHU Nantes, Institut des Maladies de l’Appareil Digestif, Nantes, France
  4. 4
    CHU Nantes, Department of Neurology, Nantes, France
  5. 5
    Inserm, CIC-04, Nantes, France
  6. 6
    CHU Nantes, Department of Anesthesia, Nantes, France
  7. 7
    Inserm, U643, Nantes, France
  1. Dr M Neunlist, Inserm U913, 1 place Alexis Ricordeau, 44093 Nantes, France; michel.neunlist{at} or Dr P Derkinderen, Department of Neurology, CHU Nantes, 44093 Nantes, France; pascal.derkinderen{at}

Statistics from

Parkinson’s disease (PD) is a neurodegenerative condition that affects 1% of the population over 65 years of age. The two pathological hallmarks of PD are a loss of dopaminergic neurons in the substantia nigra (SN) and the presence of cytoplasmic eosinophilic inclusions termed Lewy bodies (LBs), whose main component is phosphorylated α-synuclein.1 This degeneration of SN neurons leads to a dopamine deficiency responsible for the major motor symptoms. Nevertheless, it has become increasingly evident that PD is a multicentric neurodegenerative process that also affects neuronal structures outside the SN.2 In this context, various reports performed on surgical or autopsy specimens have shown that the enteric nervous system (ENS) is affected during PD.3 4 However, it is still a matter of debate whether these alterations occur early in the course of the disease. This is mainly due to a lack of accessibility to the ENS in the living patients. Therefore, demonstrating (1) the ability to study the ENS using routine colonic biopsies and (2) the presence of lesions characteristics …

View Full Text


  • Funding: This work was supported by a grant from France Parkinson, ADPLA (association des parkinsoniens de Loire Atlantique), Groupement de Parkinsoniens de Vendée and Inserm/DHOS (to PDe and MN). PDe and MN are recipients of a Contrat d’Interface Inserm.

  • Competing interests: None.

  • Ethics approval: The study protocol was approved by the local Committee on Ethics and Human Research on 27 February 2007.

  • TC and TL as well as PD and MN contributed equally to this work.

Request Permissions

If you wish to reuse any or all of this article please use the link below which will take you to the Copyright Clearance Center’s RightsLink service. You will be able to get a quick price and instant permission to reuse the content in many different ways.